(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) fell 9.44% to $4.03 at 11:56 EST on Wednesday, following the last session’s upward trend. NASDAQ is sliding 0.43% to $13,219.74, following the last session’s upward trend. This seems, so far, a somewhat down trend trading session today.
TherapeuticsMD’s last close was $4.45, 61.93% below its 52-week high of $11.69.
About TherapeuticsMD
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Earnings Per Share
As for profitability, TherapeuticsMD has a trailing twelve months EPS of $1.99.
PE Ratio
TherapeuticsMD has a trailing twelve months price to earnings ratio of 2.03. Meaning, the purchaser of the share is investing $2.03 for every dollar of annual earnings.
Volatility
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was 2.39%, 0.79%, and 3.46%.
TherapeuticsMD’s highest amplitude of average volatility was 3.00% (last week), 3.28% (last month), and 3.46% (last quarter).
Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $4.03 at 11:56 EST, way under its 52-week high of $11.69 and way higher than its 52-week low of $3.25.
Earnings Before Interest, Taxes, Depreciation, and Amortization
TherapeuticsMD’s EBITDA is 0.2.
More news about TherapeuticsMD (TXMD).
